Welsh, K J; Huang, R S P; Actor, J K; Dasgupta, A (2019-03-05). "Rapid Detection of the Active Cardiac Glycoside Convallatoxin of Lily of the Valley Using LOCI Gigoxin Assay". American Journal of Clinical Pathology. 142 (3): 307–312. doi:10.1309/AJCPCOXF0O5XXTKD. PMID25125619.
Patel, S (2016). "Plant-derived cardiac glycosides: Role in heart ailments and cancer management". Biomedicine & Pharmacotherapy. 84: 1036–1041. doi:10.1016/j.biopha.2016.10.030. PMID27780131.
Gozalpour, E; Greupink, R; Bilos, A; Verweij, V; van den Heuvel, JJ; Masereeuw, R; Russel, FG; Koenderink, JB (2014). "Convallatoxin: a new P-glycoprotein substrate". European Journal of Pharmacology. 744: 18–27. doi:10.1016/j.ejphar.2014.09.031. PMID25264938.
Gozalpour, E; Wilmer, MJ; Bilos, A; Masereeuw, R; Russel, FG; Koenderink, JB (2016). "Heterogeneous transport of digitalis-like compounds by P-glycoprotein in vesicular and cellular assays". Toxicology in Vitro. 32: 138–145. Bibcode:2016ToxVi..32..138G. doi:10.1016/j.tiv.2015.12.009. PMID26708294.
Levrier, C; Kiremire, B; Guéritte, F; Litaudon, M (2012). "Toxicarioside M, a new cytotoxic 10β-hydroxy-19-nor-cardenolide from Antiaris toxicaria". Fitoterapia. 83 (4): 660–664. doi:10.1016/j.fitote.2012.02.001. PMID22348979.
Angarskaya, MA; Topchii, LY (1973). "Experimental results relating to the metabolism of the cardiac glycosides". Chemistry of Natural Compounds. 9 (5): 621–624. doi:10.1007/BF00564387. S2CID4820710.
Xu, J; Guo, Y; Sui, T; Wang, Q; Zhang, Y; Zhang, R; Wang, M; Guan, S; Wang, L (2017). "Molecular mechanisms of anti-oxidant and anti-aging effects induced by convallatoxin in Caenorhabditis elegans". Free Radical Research. 51 (5): 529–544. doi:10.1080/10715762.2017.1331037. PMID28503972. S2CID3830979.
Welsh, K J; Huang, R S P; Actor, J K; Dasgupta, A (2019-03-05). "Rapid Detection of the Active Cardiac Glycoside Convallatoxin of Lily of the Valley Using LOCI Gigoxin Assay". American Journal of Clinical Pathology. 142 (3): 307–312. doi:10.1309/AJCPCOXF0O5XXTKD. PMID25125619.
Patel, S (2016). "Plant-derived cardiac glycosides: Role in heart ailments and cancer management". Biomedicine & Pharmacotherapy. 84: 1036–1041. doi:10.1016/j.biopha.2016.10.030. PMID27780131.
Gozalpour, E; Greupink, R; Bilos, A; Verweij, V; van den Heuvel, JJ; Masereeuw, R; Russel, FG; Koenderink, JB (2014). "Convallatoxin: a new P-glycoprotein substrate". European Journal of Pharmacology. 744: 18–27. doi:10.1016/j.ejphar.2014.09.031. PMID25264938.
Gozalpour, E; Wilmer, MJ; Bilos, A; Masereeuw, R; Russel, FG; Koenderink, JB (2016). "Heterogeneous transport of digitalis-like compounds by P-glycoprotein in vesicular and cellular assays". Toxicology in Vitro. 32: 138–145. Bibcode:2016ToxVi..32..138G. doi:10.1016/j.tiv.2015.12.009. PMID26708294.
Levrier, C; Kiremire, B; Guéritte, F; Litaudon, M (2012). "Toxicarioside M, a new cytotoxic 10β-hydroxy-19-nor-cardenolide from Antiaris toxicaria". Fitoterapia. 83 (4): 660–664. doi:10.1016/j.fitote.2012.02.001. PMID22348979.
Xu, J; Guo, Y; Sui, T; Wang, Q; Zhang, Y; Zhang, R; Wang, M; Guan, S; Wang, L (2017). "Molecular mechanisms of anti-oxidant and anti-aging effects induced by convallatoxin in Caenorhabditis elegans". Free Radical Research. 51 (5): 529–544. doi:10.1080/10715762.2017.1331037. PMID28503972. S2CID3830979.
Prassas, I; Diamandis, EP (2008). "Novel therapeutic applications of cardiac glycosides". Nature Reviews Drug Discovery. 7 (11): 926–35. doi:10.1038/nrd2682. PMID18948999. S2CID14459328.
Angarskaya, MA; Topchii, LY (1973). "Experimental results relating to the metabolism of the cardiac glycosides". Chemistry of Natural Compounds. 9 (5): 621–624. doi:10.1007/BF00564387. S2CID4820710.
Xu, J; Guo, Y; Sui, T; Wang, Q; Zhang, Y; Zhang, R; Wang, M; Guan, S; Wang, L (2017). "Molecular mechanisms of anti-oxidant and anti-aging effects induced by convallatoxin in Caenorhabditis elegans". Free Radical Research. 51 (5): 529–544. doi:10.1080/10715762.2017.1331037. PMID28503972. S2CID3830979.